A Mab A Case Study In Bioprocess Development ((hot)) Review
This article is a synthetic case study representative of standard industrial practices for monoclonal antibody development. Actual processes for commercial antibodies (e.g., Humira, Keytruda, Rituxan) vary in specifics but follow the same engineering principles outlined above.
